Strictly Business

A Business Law Blog for Entrepreneurs, Startups, Venture Capital, and the Private Fund Industry.

  • About the Authors
    • Alexander J. Davie
    • Casey W. Riggs
    • J. Chandler Waits
    • Jennifer Wilson
    • Taylor K. Wilkins
  • Categories
    • Effective Attorney-Client Relationships
    • General Business Law
    • Intellectual Property
    • Mergers & Acquisitions
    • Private Equity and Hedge Funds
    • Startups and Venture Capital
    • Technology
  • Guides
    • Exempt Reporting Adviser Filing Requirements
    • State Investment Adviser Registration

Bankruptcy Archives

Neogenix Oncology: A Good Case Study on Securities Law (Non)Compliance by a High Growth Company – Part 3: When the Genie Can’t Be Put Back in the Bottle

November 16, 2012 by Alexander J. Davie

In my previous posts, I described the events leading up to the Chapter 11 bankruptcy and supervised asset sale of Neogenix Oncology. To recap, Neogenix’s payment of fees to unregistered “finders” to raise money in some of its earlier rounds of financing called into question the company’s compliance with federal and state securities laws. Under such laws, just about any arrangement in which someone is paid a contingent or variable fee to raise capital for a company is prohibited, unless that person is registered as a broker-dealer or is a registered representative of a broker-dealer. After the SEC commenced an investigation into Neogenix’s practices, the company’s accountants concluded that potential investor lawsuits and/or governmental enforcement actions could give rise to large contingent liabilities on the company’s balance sheet. This uncertainty led to Neogenix being unable to raise further funds, necessitating the company’s bankruptcy filing. In this post, I’ll explore the likely reason why Neogenix had to take the drastic step of filing for bankruptcy to cure its securities violations. [Read more…]

Share this:

  • Twitter
  • LinkedIn

Filed Under: General Business Law Tagged With: Bankruptcy, Broker-Dealer, Finders Fees, Neogenix Oncology, Rescission, Rescission Offer, SEC, Securities, Securities Exchange Act, Success Fee

About the editor

Alexander Davie image
Strictly Business is a business law blog for entrepreneurs, startups, venture capital, and the private fund industry. Its editor is Alexander J. Davie, an attorney at Riggs Davie PLC based in Nashville, Tennessee. His practice focuses on corporate, securities, and business law. He works mainly with technology companies, including startups and emerging companies, and private equity, venture capital, and hedge funds.
Contact Alex

Connect

Categories

  • Effective Attorney-Client Relationships
  • General Business Law
  • Intellectual Property
  • Mergers & Acquisitions
  • Private Equity and Hedge Funds
  • Startups and Venture Capital
  • Technology

Subscribe

Sign up today to receive ongoing updates from Strictly Business.
© 2011–2021 - Alexander J. Davie | Attorney Advertising | Privacy Policy